Volume 26, Number 7—July 2020
CME ACTIVITY - Research
Atypical Manifestations of Cat-Scratch Disease, United States, 2005–2014
Table 2
Characteristic | No. (%) | Sex, no. (%) |
Age category, y, no. (%) |
Hospitalized, no. (%) | ||||
---|---|---|---|---|---|---|---|---|
M | F | 0–14 | 15–49 | 50–64 | ||||
Atypical disease | 224* | 94 (42.0) | 130 (58.0) | 81 (36.2) | 106 (47.3) | 37 (16.5) | 56 (25.0) | |
Ocular disease | 109 (48.7) | 46 (48.9) | 63 (48.5) | 33 (40.7) | 60 (56.6) | 16 (43.2) | 10 (17.9) | |
Retinitis/neuroretinitis | 90 (40.2) | 36 (38.3) | 54 (41.5) | 23 (28.4) | 53 (50.0) | 14 (37.8) | 8 (14.3) | |
Conjunctivitis | 19 (8.5) | 10 (10.6) | 9 (6.9) | 10 (12.3) | 7 (6.6) | 2(5.4) | 2 (3.6) | |
Hepatosplenic disease | 55 (24.6) | 24 (25.5) | 31 (23.8) | 25 (30.9) | 21 (19.8) | 9 (24.3) | 24 (42.9) | |
Neurologic disease | 31 (13.8) | 13 (13.8) | 18 (13.8) | 12 (14.8) | 13 (12.3) | 6 (16.2) | 13 (23.2) | |
Encephalitis | 20 (8.9) | 12 (12.8) | 8 (6.2) | 12 (14.8) | 8 (7.5) | 0 (0) | 13 (23.2) | |
Neuritis | 11 (4.9) | 1 (1.1) | 10 (7.7) | 0 (0) | 5 (4.7) | 6 (16.2) | 0 (0) | |
Osteomyelitis | 14 (6.3) | 6 (6.4) | 8 (6.2) | 9 (11.1) | 4 (3.8) | 1 (2.7) | 7 (12.5) | |
Erythema nodosum | 11 (4.9) | 2 (2.1) | 9 (6.9) | 4 (4.9) | 5 (4.7) | 2 (5.4) | 4 (7.1) | |
Endocarditis | 8 (3.6) | 4 (4.3) | 4 (3.1) | 1 (1.2) | 4 (3.8) | 3 (8.1) | 2 (3.6) |
*A total of 228 manifestations of atypical cat-scratch disease were seen among 224 patients. Three patients had >1 manifestation; 1 patient had osteomyelitis and hepatosplenic disease;1 patient had endocarditis and hepatosplenic disease; and 1 patient had osteomyelitis, encephalitis, and hepatosplenic disease.
1Current affiliation: University of North Carolina, Chapel Hill, North Carolina, USA.
2Current affiliation: Colorado Department of Public Health and Environment, Denver, Colorado, USA.
Page created: March 20, 2020
Page updated: June 17, 2020
Page reviewed: June 17, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.